Systematic development and optimization of a microfluidic formulation protocol for liposomal azithromycin
{{output}}
Delivery of azithromycin via liposomal formulation (L-AZM) has been shown to improve the therapeutic index and activity of AZM in a preclinical model of cardiac injury, suggesting strong potential for clinical translation to treat inflammation after a myocardi... ...
